Account wins

Share this article:
Galderma Laboratories has awarded agency of record for advertising and promotion for three products in the corrective and aesthetic market to Brand Pharm, a member of the Publicis Healthcare Communications Group of agencies. Two of the products – Pliaglistm (7% lidocaine/7 % tetracaine), a topical anesthetic, and Elevesstm, a cosmetic filler - are new products. The third product – Tri-Luma (fluocinolone acetonide 0.01%, hydroquinone 4%, tretinoin 0.05%), a treatment for melasma, a hyperpigmentation disorder - was already a Brand Pharm assignment for medical promotions. These new assignments increase the total to five products the agency's assignments with Galderma. Brand Pharm has had the agency assignment for Differin (adapalene), a prescription treatment for acne, and Metrogel (metronidazole gel, 1%), one of the leading therapies prescribed by dermatologists for rosacea.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Apple selfies spur diabetes donations

Jazz apples has launched a Crunch to Contribute campaign to raise money for one of two diabetes associations.

Baxter seeks Cambridge, Mass. HQ

Illinois may be tempted to offer tax incentives for the firm to stay put.

FDA wants Alexion to clean up

FDA inspectors have cited the manufacturer of the rare-disease drug Soliris (eculizumab) for poor manufacturing practices.